Lewis M E, Solh H, Poon A, Dubé I D
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Cancer Genet Cytogenet. 1991 Aug;55(1):85-8. doi: 10.1016/0165-4608(91)90239-q.
We report a case of pediatric acute non-lymphocytic leukemia (ANLL) with monosomy 7 occurring in a child successfully treated for acute lymphoblastic leukemia (ALL) nine years earlier. Acquired monosomy 7 is currently recognized as a distinct therapy-related cytogenetic abnormality which nonrandomly occurs as a late complication of cytotoxic therapy used in the treatment of both malignant and nonmalignant disease. Most commonly, this occurs as a disorder of bone marrow morphology and function characterized as a myelodysplastic syndrome (MDS) or ANLL. This case report emphasizes the need for continued evaluation of long-term survivors of childhood cancer to identify and minimize therapy-related side effects without compromising successful management.
我们报告了一例小儿急性非淋巴细胞白血病(ANLL)伴7号染色体单体的病例,该患儿9年前曾成功治疗过急性淋巴细胞白血病(ALL)。获得性7号染色体单体目前被认为是一种独特的与治疗相关的细胞遗传学异常,它作为细胞毒性疗法治疗恶性和非恶性疾病的晚期并发症并非随机发生。最常见的情况是,它表现为骨髓形态和功能紊乱,特征为骨髓增生异常综合征(MDS)或ANLL。本病例报告强调了对儿童癌症长期幸存者进行持续评估的必要性,以便在不影响成功治疗的前提下识别并尽量减少与治疗相关的副作用。